Flow Mediated Skin Fluorescence technique reveals remarkable effect of age on microcirculation and metabolic regulation in type 1 diabetes.


Journal

Microvascular research
ISSN: 1095-9319
Titre abrégé: Microvasc Res
Pays: United States
ID NLM: 0165035

Informations de publication

Date de publication:
07 2019
Historique:
received: 12 12 2018
revised: 22 02 2019
accepted: 22 02 2019
pubmed: 27 2 2019
medline: 19 6 2019
entrez: 27 2 2019
Statut: ppublish

Résumé

Flow Mediated Skin Fluorescence (FMSF) is a novel technique for non-invasive evaluation of the microcirculation and metabolic regulation. This study describes the diagnostic potential of FMSF for type 1 diabetes (DM1). All study participants, in both the control (n = 31) and DM1 (n = 40) groups, were between the ages of 30-49 y. The patients in the DM1 group had all been suffering from diabetes for at least 10 y. The parameters HR FMSF appears to be an extremely useful technique for monitoring diabetic patients over time, enabling early diagnosis of potentially dysfunctional microcirculation and metabolic regulation.

Identifiants

pubmed: 30807771
pii: S0026-2862(18)30314-5
doi: 10.1016/j.mvr.2019.02.005
pii:
doi:

Substances chimiques

Biomarkers 0
NAD 0U46U6E8UK

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19-24

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Joanna Katarzynska (J)

Angionica Ltd., Lodz, Poland.

Anna Borkowska (A)

Department of Internal Diseases and Diabetology, Medical University of Lodz, Lodz, Poland.

Przemyslaw Czajkowski (P)

Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland.

Agnieszka Los (A)

Department of Internal Diseases and Diabetology, Medical University of Lodz, Lodz, Poland.

Lukasz Szczerbinski (L)

Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.

Agnieszka Milewska-Kranc (A)

Clinical Service, Warsaw, Poland.

Andrzej Marcinek (A)

Angionica Ltd., Lodz, Poland; Institute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland.

Adam Kretowski (A)

Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland; Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.

Katarzyna Cypryk (K)

Department of Internal Diseases and Diabetology, Medical University of Lodz, Lodz, Poland.

Jerzy Gebicki (J)

Angionica Ltd., Lodz, Poland; Institute of Applied Radiation Chemistry, Lodz University of Technology, Lodz, Poland. Electronic address: jerzy.gebicki@p.lodz.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH